Difficulty: Medium
Average Score: 93%
Practice
A floor nurse pages you about a patient who is having a chest pain. You order an electro-cardiogram and rush to see the patient. He describes the pain as tight pressure and is demonstrably sweating and gasping for air. The ECG comes back with acute ST-segment elevations in inferior leads, and you diagnose a myocardial infarction. You start giving the patient oxygen and give him sublingual nitro-glycerin and morphine for pain. You also give him another medication, which you have read may prolong his survival in this situation. What class of medication is it?
Correct answer
A
Rationale
The correct answer is A) ß-Blocker. In the scenario of a myocardial infarction, ß-Blockers are crucial in improving patient outcomes. ß-Blockers reduce myocardial oxygen demand by decreasing heart rate, blood pressure, and contractility, thereby reducing the workload of the heart during an acute event like a heart attack. They also help prevent arrhythmias and reduce the risk of future cardiac events.
Option B) ╬▒-Agonist is incorrect because alpha agonists would increase blood pressure and heart rate, which can be detrimental in a myocardial infarction.
Option C) Muscarinic agonist is incorrect because muscarinic agonists would lead to a decrease in heart rate and worsen the patient's condition during a myocardial infarction.
Option D) Neuromuscular blocker is incorrect because it is used for muscle relaxation during surgeries and not indicated in the treatment of myocardial infarction.
Understanding the pharmacological management of myocardial infarction and the rationale behind each medication choice is crucial for healthcare providers to provide optimal care to patients in acute settings. Understanding the mechanisms of action of different drug classes helps in making informed decisions and providing evidence-based care to improve patient outcomes.
Option B) ╬▒-Agonist is incorrect because alpha agonists would increase blood pressure and heart rate, which can be detrimental in a myocardial infarction.
Option C) Muscarinic agonist is incorrect because muscarinic agonists would lead to a decrease in heart rate and worsen the patient's condition during a myocardial infarction.
Option D) Neuromuscular blocker is incorrect because it is used for muscle relaxation during surgeries and not indicated in the treatment of myocardial infarction.
Understanding the pharmacological management of myocardial infarction and the rationale behind each medication choice is crucial for healthcare providers to provide optimal care to patients in acute settings. Understanding the mechanisms of action of different drug classes helps in making informed decisions and providing evidence-based care to improve patient outcomes.